Quark Pharmaceuticals Inc - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 48 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Quark Pharmaceuticals Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Quark Pharmaceuticals Inc - Product Pipeline Review - 2016', provides an overview of the Quark Pharmaceuticals Inc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Quark Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Quark Pharmaceuticals Inc
- The report provides overview of Quark Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Quark Pharmaceuticals Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Quark Pharmaceuticals Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Quark Pharmaceuticals Inc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Quark Pharmaceuticals Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Quark Pharmaceuticals Inc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Quark Pharmaceuticals Inc Snapshot 7
Quark Pharmaceuticals Inc Overview 7
Key Facts 7
Quark Pharmaceuticals Inc - Research and Development Overview 8
Key Therapeutic Areas 8
Quark Pharmaceuticals Inc - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Pipeline Products - Out-Licensed Products 15
Out-Licensed Products/Combination Treatment Modalities 16
Quark Pharmaceuticals Inc - Pipeline Products Glance 17
Quark Pharmaceuticals Inc - Late Stage Pipeline Products 17
Phase III Products/Combination Treatment Modalities 17
Quark Pharmaceuticals Inc - Clinical Stage Pipeline Products 18
Phase II Products/Combination Treatment Modalities 18
Quark Pharmaceuticals Inc - Early Stage Pipeline Products 19
Preclinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
Quark Pharmaceuticals Inc - Drug Profiles 21
QPAL-1 - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
QPAL-2 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
QPCO-1 - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
QPCP-1 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
QPEN-1 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
QPEN-2 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
QPHL-1 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
QPHL-2 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
QPHL-3 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
QPI-1002 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
QPI-1007 - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
QPI-1024 - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
QPLI-1 - Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
QPLI-2 - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
QPNR-1 - Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
Quark Pharmaceuticals Inc - Pipeline Analysis 42
Quark Pharmaceuticals Inc - Pipeline Products by Target 42
Quark Pharmaceuticals Inc - Pipeline Products by Route of Administration 43
Quark Pharmaceuticals Inc - Pipeline Products by Molecule Type 44
Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action 45
Quark Pharmaceuticals Inc - Dormant Projects 46
Quark Pharmaceuticals Inc - Locations And Subsidiaries 47
Head Office 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49

List of Tables

Quark Pharmaceuticals Inc, Key Facts 7
Quark Pharmaceuticals Inc - Pipeline by Indication, 2016 9
Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016 11
Quark Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016 12
Quark Pharmaceuticals Inc - Partnered Products in Pipeline, 2016 13
Quark Pharmaceuticals Inc - Partnered Products/ Combination Treatment Modalities, 2016 14
Quark Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016 15
Quark Pharmaceuticals Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 16
Quark Pharmaceuticals Inc - Phase III, 2016 17
Quark Pharmaceuticals Inc - Phase II, 2016 18
Quark Pharmaceuticals Inc - Preclinical, 2016 19
Quark Pharmaceuticals Inc - Discovery, 2016 20
Quark Pharmaceuticals Inc - Pipeline by Target, 2016 42
Quark Pharmaceuticals Inc - Pipeline by Route of Administration, 2016 43
Quark Pharmaceuticals Inc - Pipeline by Molecule Type, 2016 44
Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016 45
Quark Pharmaceuticals Inc - Dormant Developmental Projects,2016 46